Cohort PLC
30 January 2007
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of listed company
Cohort Plc
2. Name of shareholder with a major interest
AXA Investment Managers UK Ltd
3. Please state whether notification indicates that it is regarding the holding
of the shareholder named in 2 above; or in respect of a non-beneficial interest;
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
Beneficial and non-beneficial
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Beneficial: 502,769
Throgmorton Trust 625,692
Framlington Innovative Growth 305,200
Framlington AIM VCT1 170,800
Framlington AIM VCT2 597,769
Non-beneficial: 201,108
AXA Framlington UK Smaller Companies 100,554
AXA Framlington Xerox Final Salary Pension Scheme 150,000
AXA Framlington Islington Group Pension Scheme
AXA Framlington SEI UK Equity
5. Number of shares / amount of stock acquired
-
6. Percentage of issued class (any treasury shares held by the listed company
should not be taken into account when calculating percentage)
-
7. Number of shares / amount of stock disposed
-
8. Percentage of issued class (any treasury shares held by the listed company
should not be taken into account when calculating percentage)
-
9. Class of security
10p Ordinary shares
10. Date of transaction
-
11. Date listed company informed
24 January 2007
12. Total holding following this notification
2,653,892
13. Total percentage holding of issued class following this notification (any
treasury shares held by the listed company should not be taken into account when
calculating percentage)
9.00%
14. Any additional information
-
15. Name of contact and telephone number for queries
Simon Walther - 01491 843150
16. Name and signature of duly authorised officer of the listed company
responsible for making this notification
Date of notification
30 January 2007
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.